Targeting of intracellular Ca2+ stores as a therapeutic strategy against age-related neurotoxicities

Abstract Calcium dysregulation often underlies pathologies associated with aging and age-associated neurodegenerative diseases. Cells express a unique pattern of Ca2+ channels and pumps geared to fulfill specific physiological requirements and there is a decline in the fidelity of these processes wi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Joshua Goldberg, Antonio Currais, Gamze Ates, Ling Huang, Maxim Shokhirev, Pamela Maher, David Schubert
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
Acceso en línea:https://doaj.org/article/aab8f71534334401ab0fe2d1f969c108
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:aab8f71534334401ab0fe2d1f969c108
record_format dspace
spelling oai:doaj.org-article:aab8f71534334401ab0fe2d1f969c1082021-12-02T16:35:11ZTargeting of intracellular Ca2+ stores as a therapeutic strategy against age-related neurotoxicities10.1038/s41514-020-00048-12056-3973https://doaj.org/article/aab8f71534334401ab0fe2d1f969c1082020-08-01T00:00:00Zhttps://doi.org/10.1038/s41514-020-00048-1https://doaj.org/toc/2056-3973Abstract Calcium dysregulation often underlies pathologies associated with aging and age-associated neurodegenerative diseases. Cells express a unique pattern of Ca2+ channels and pumps geared to fulfill specific physiological requirements and there is a decline in the fidelity of these processes with age and age-associated diseases. J147 is an Alzheimer’s disease (AD) drug candidate that was identified using a phenotypic screening platform based upon age-related brain toxicities that are mediated by changes in calcium metabolism. The molecular target for J147 is the α-F1-ATP synthase (ATP5A). J147 has therapeutic efficacy in multiple mouse models of AD and accelerated aging and extends life span in flies. A bioinformatics analysis of gene expression in rapidly aging SAMP8 mice during the last quadrant of their life span shows that J147 has a significant effect on ion transport pathways that are changed with aging, making their expression look more like that of younger animals. The molecular basis of these changes was then investigated in cell culture neurotoxicity assays that were the primary screen in the development of J147. Here we show that J147 and its molecular target, ATP synthase, regulate the maintenance of store-operated calcium entry (SOCE) and cell death during acute neurotoxicity.Joshua GoldbergAntonio CurraisGamze AtesLing HuangMaxim ShokhirevPamela MaherDavid SchubertNature PortfolioarticleGeriatricsRC952-954.6ENnpj Aging and Mechanisms of Disease, Vol 6, Iss 1, Pp 1-9 (2020)
institution DOAJ
collection DOAJ
language EN
topic Geriatrics
RC952-954.6
spellingShingle Geriatrics
RC952-954.6
Joshua Goldberg
Antonio Currais
Gamze Ates
Ling Huang
Maxim Shokhirev
Pamela Maher
David Schubert
Targeting of intracellular Ca2+ stores as a therapeutic strategy against age-related neurotoxicities
description Abstract Calcium dysregulation often underlies pathologies associated with aging and age-associated neurodegenerative diseases. Cells express a unique pattern of Ca2+ channels and pumps geared to fulfill specific physiological requirements and there is a decline in the fidelity of these processes with age and age-associated diseases. J147 is an Alzheimer’s disease (AD) drug candidate that was identified using a phenotypic screening platform based upon age-related brain toxicities that are mediated by changes in calcium metabolism. The molecular target for J147 is the α-F1-ATP synthase (ATP5A). J147 has therapeutic efficacy in multiple mouse models of AD and accelerated aging and extends life span in flies. A bioinformatics analysis of gene expression in rapidly aging SAMP8 mice during the last quadrant of their life span shows that J147 has a significant effect on ion transport pathways that are changed with aging, making their expression look more like that of younger animals. The molecular basis of these changes was then investigated in cell culture neurotoxicity assays that were the primary screen in the development of J147. Here we show that J147 and its molecular target, ATP synthase, regulate the maintenance of store-operated calcium entry (SOCE) and cell death during acute neurotoxicity.
format article
author Joshua Goldberg
Antonio Currais
Gamze Ates
Ling Huang
Maxim Shokhirev
Pamela Maher
David Schubert
author_facet Joshua Goldberg
Antonio Currais
Gamze Ates
Ling Huang
Maxim Shokhirev
Pamela Maher
David Schubert
author_sort Joshua Goldberg
title Targeting of intracellular Ca2+ stores as a therapeutic strategy against age-related neurotoxicities
title_short Targeting of intracellular Ca2+ stores as a therapeutic strategy against age-related neurotoxicities
title_full Targeting of intracellular Ca2+ stores as a therapeutic strategy against age-related neurotoxicities
title_fullStr Targeting of intracellular Ca2+ stores as a therapeutic strategy against age-related neurotoxicities
title_full_unstemmed Targeting of intracellular Ca2+ stores as a therapeutic strategy against age-related neurotoxicities
title_sort targeting of intracellular ca2+ stores as a therapeutic strategy against age-related neurotoxicities
publisher Nature Portfolio
publishDate 2020
url https://doaj.org/article/aab8f71534334401ab0fe2d1f969c108
work_keys_str_mv AT joshuagoldberg targetingofintracellularca2storesasatherapeuticstrategyagainstagerelatedneurotoxicities
AT antoniocurrais targetingofintracellularca2storesasatherapeuticstrategyagainstagerelatedneurotoxicities
AT gamzeates targetingofintracellularca2storesasatherapeuticstrategyagainstagerelatedneurotoxicities
AT linghuang targetingofintracellularca2storesasatherapeuticstrategyagainstagerelatedneurotoxicities
AT maximshokhirev targetingofintracellularca2storesasatherapeuticstrategyagainstagerelatedneurotoxicities
AT pamelamaher targetingofintracellularca2storesasatherapeuticstrategyagainstagerelatedneurotoxicities
AT davidschubert targetingofintracellularca2storesasatherapeuticstrategyagainstagerelatedneurotoxicities
_version_ 1718383711556206592